Table 3 Correlation of leptin expression with clinicopathological characteristics of patients with hepatocellular carcinoma (n = 68).
Variables | n | Leptin | ||
---|---|---|---|---|
Low | High | p Value* | ||
Liver cirrhosis | 0.085 | |||
Negative | 39 | 12 | 27 | |
Positive | 27 | 14 | 13 | |
Vascular invasion | 0.230 | |||
Negative | 46 | 16 | 30 | |
Positive | 22 | 11 | 11 | |
Capsular invasion | 0.110 | |||
Negative | 48 | 22 | 26 | |
Positive | 20 | 5 | 15 | |
α‐fetoprotein (ng/ml) | 0.273 | |||
<200 | 42 | 17 | 15 | |
⩾200 | 16 | 4 | 12 | |
Tumour size (cm) | 0.457 | |||
<5 | 39 | 14 | 25 | |
⩾5 | 29 | 13 | 16 | |
Tumour grade | 0.361 | |||
I | 12 | 4 | 8 | |
II | 48 | 18 | 30 | |
III | 8 | 5 | 3 | |
Tumour stage | 0.298 | |||
I or II | 50 | 18 | 32 | |
III or IV | 18 | 9 | 9 | |
MVD | 0.032 | |||
Low | 37 | 19 | 18 | |
High | 31 | 8 | 23 | |
Ki‐67 | 0.979 | |||
Low (S1 or S2) | 53 | 21 | 32 | |
High (S3 or S4) | 15 | 6 | 9 |
MVD, microvessel density.
S1, ⩽25% positive cells; S2, 26–50% positive cells; S3, 51–75% positive cells; S4, ⩾76% positive cells.
*By χ2 test.